Data / Form D filings / PRECIGEN, INC.
PRECIGEN, INC.: Form D filings
PRECIGEN, INC., a pharmaceuticals company in Germantown, MD, filed 26 Form D notices with the SEC between 2009 and 2020. The latest, on December 17, 2020, reports $13 million sold of a $13 million offering to 2 investors.
Find out what PRECIGEN, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20374 SENECA MEADOWS PARKWAY, Germantown, MD, 20876
- Phone
- (301) 556-9900
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Virginia
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1356090
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 17, 2020 | New notice | $13,000,000 | $13,000,000 | $0 | 2 | Dec 2, 2020 | sec.gov |
| Feb 11, 2020 | New notice | $35,000,000 | $35,000,000 | $0 | 1 | Jan 31, 2020 | sec.gov |
| Mar 9, 2016 | New notice | $4,250,000 | $4,250,000 | $0 | 2 | Feb 24, 2016 | sec.gov |
| Sep 21, 2015 | New notice | $21,585,401 | $21,585,401 | $0 | 20 | Sep 4, 2015 | sec.gov |
| Mar 11, 2015 | New notice | $450,015 | $450,015 | $0 | 1 | Feb 24, 2015 | sec.gov |
| Mar 9, 2015 | New notice | $10,196,546 | $10,196,546 | $0 | 78 | Feb 23, 2015 | sec.gov |
| Jan 28, 2015 | New notice | $57,500,000 | $57,500,000 | $0 | 1 | Jan 13, 2015 | sec.gov |
| Aug 22, 2014 | New notice | $28,634,166 | $28,634,166 | $0 | 5 | Aug 8, 2014 | sec.gov |
| Apr 10, 2014 | New notice | $24,999,943 | $24,999,943 | $0 | 5 | Mar 27, 2014 | sec.gov |
| May 15, 2013 | Amendment | $150,000,000 | $150,000,000 | $0 | 82 | Mar 1, 2013 | sec.gov |
| Mar 18, 2013 | New notice | $150,000,000 | $64,409,342 | $85,590,658 | 57 | Mar 1, 2013 | sec.gov |
| Nov 15, 2012 | New notice | $25,000,002 | $25,000,002 | $0 | 16 | Oct 26, 2012 | sec.gov |
| Apr 26, 2012 | Amendment | $75,000,006 | $75,000,006 | $0 | 81 | Dec 23, 2011 | sec.gov |
| Jan 24, 2012 | Amendment | $50,000,003 | $50,000,003 | $0 | 42 | Dec 23, 2011 | sec.gov |
| Jan 9, 2012 | New notice | $50,000,000 | $17,000,000 | $33,000,000 | 2 | Dec 23, 2011 | sec.gov |
| Nov 14, 2011 | New notice | $1,092,344 | $1,092,344 | $0 | 17 | Oct 31, 2011 | sec.gov |
| Sep 14, 2011 | New notice | $17,000,004 | $17,000,004 | $0 | 1 | Aug 31, 2011 | sec.gov |
| Jun 8, 2011 | New notice | $91,825,055 | $91,825,055 | $0 | 58 | May 26, 2011 | sec.gov |
| May 11, 2011 | New notice | $550,001 | $550,001 | $0 | 1 | Apr 18, 2011 | sec.gov |
| Apr 22, 2011 | Amendment | $66,936,470 | $66,936,470 | $0 | 82 | Feb 19, 2010 | sec.gov |
| Feb 18, 2011 | Amendment | $55,953,968 | $55,953,968 | $0 | 82 | Feb 19, 2010 | sec.gov |
| Feb 9, 2011 | New notice | $1,346,625 | $1,013,625 | $333,000 | 3 | Jan 26, 2011 | sec.gov |
| Nov 12, 2010 | Amendment | $37,506,714 | $37,506,714 | $0 | 65 | Feb 19, 2010 | sec.gov |
| Mar 5, 2010 | New notice | $17,403,901 | $17,403,901 | $0 | 40 | Feb 19, 2010 | sec.gov |
| Jan 5, 2010 | New notice | $25,000,000 | $25,000,000 | $0 | 2 | Dec 22, 2009 | sec.gov |
| Jun 29, 2009 | New notice | $9,999,999 | $9,999,999 | $0 | 1 | Jun 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rick L. Sterling | Executive Officer | |
| Donald P. Lehr | Executive Officer | |
| Jeffrey P. Perez | Executive Officer | |
| Helen P. Sabzevari, Ph.D. | Executive Officer, Director | |
| Randal J. Kirk | Director | |
| Cesar L. Alvarez | Director | |
| James S. Turley | Director | |
| Vinita D. Gupta | Director | |
| Fred D. Hassan | Director | |
| Jeffrey B. Kindler | Director | |
| Dean J. Mitchell | Director | |
| Robert B. Shapiro | Director | |
| Steven L. Frank | Director |
Every Form D from the week of Dec 14, 2020 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PRECIGEN, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.